In the realm of fine chemicals, understanding the intrinsic properties and manufacturing nuances of key intermediates is crucial for innovation and product development. NINGBO INNO PHARMCHEM CO.,LTD. focuses on providing detailed information on compounds like 1-(4-fluorophenyl)butan-1-one, identified by CAS number 582-83-2. This chemical entity serves as a foundational element in the synthesis of a wide array of complex organic molecules, particularly within the pharmaceutical industry.

The compound, 1-(4-fluorophenyl)butan-1-one, possesses the molecular formula C10H11FO and a molecular weight of 166.19. It is typically a white solid, with a melting point around 38°C and a boiling point of 102°C. NINGBO INNO PHARMCHEM CO.,LTD. emphasizes the high purity of this intermediate, often ensuring levels exceed 97%, a critical factor for its application in sensitive synthetic pathways where precision is paramount. The presence of the fluorine atom on the phenyl ring imparts unique electronic characteristics, influencing its reactivity and the properties of the molecules derived from it.

The '1-(4-fluorophenyl)butan-1-one synthesis' often involves established chemical reactions, such as the Friedel-Crafts acylation. NINGBO INNO PHARMCHEM CO.,LTD. continually refines these manufacturing processes to maximize yield and purity while minimizing environmental impact. For manufacturers and researchers seeking 'high purity 1-(4-fluorophenyl)butan-1-one,' understanding the supplier's commitment to quality control and manufacturing excellence is essential. The CAS number 582-83-2 serves as a universal identifier, ensuring that the correct compound is sourced globally.

The applications for '4'-fluorobutyrophenone' are diverse, ranging from its use as a key intermediate in the synthesis of antipsychotic drugs to its role in the development of new chemical entities. NINGBO INNO PHARMCHEM CO.,LTD. supports these efforts by providing a consistent and reliable supply of this vital chemical. By offering a deep understanding of the 'CAS 582-83-2 properties' and manufacturing capabilities, the company empowers its clients to accelerate their research and development initiatives, ultimately contributing to advancements in science and medicine.